by Tator Law | May 23, 2020 | Malpractice Law
Elmiron (pentosan polysulfate sodium), a drug widely prescribed for a bladder condition, has been associated with eye damage. Hundreds of thousands of people who have taken Elmiron may have been exposed to the risk of potentially permanent vision damage. Recent...
by Tator Law | May 16, 2020 | Malpractice Law
Since the CARES Act (also referred to as the Paycheck Protection Act, or “PPP”) rolled out on April 3, 2020, COVID-19-affected small businesses have claimed that banks processed loan applications to benefit themselves, rather than on the “first-come, first-served”...
by Tator Law | Feb 1, 2020 | Malpractice Law
Stem cell treatments have been defined as both miracle treatments and snake oil. The public has heard from researchers and licensed doctors, unlicensed frauds and for-profit companies that stem cell therapy can regenerate hair and organs, cure cancer and emphysema,...
by Tator Law | Oct 19, 2019 | Malpractice Law
Zantac (ranitidine hydrochloride) is being investigated after 150 Zantac tablets were found to contain a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit. The chemical found in the popular heartburn drug is N-nitrosodimethylamine...
by Tator Law | Aug 31, 2019 | Malpractice Law
The Defense Base Act (DBA) is a federal law that provides Worker’s Compensation and Death Benefits for civilian employees working outside the United States on U.S. military bases or under a contract with the U.S. government for public works or for national defense,...
by Tator Law | Jul 20, 2019 | Malpractice Law
Ford announced in February 2019 that its fuel economy ratings were not accurate on some of its vehicles due to its fuel economy testing procedures. As a result of the automaker’s admittedly flawed testing, a Ford Fuel Economy class action lawsuit has been filed on...
